Interested in the human brain and biophysics, Carol Huseby earned double B.Sc. degrees in Physics and Biology at the University of Washington Seattle and pursued a master’s degree in Applied Mathematics where she studied neuronal firing models. Her Ph.D. was then completed in biophysics at The Ohio State University focusing on Alzheimer’s disease and its pathological marker tau protein aggregation. She was then awarded an NRSA NIH Postdoctoral fellowship from University of Arizona and ASU through the Arizona Alzheimer’s Consortium where she compared transcriptional changes in multiple neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease), frontotemporal dementia, Huntingtons’ disease, Friedreich’s ataxia, and others. Her lab research centers around the differences between neurodegenerative disease which lead to formation of pathological lesions and clinical symptoms distinct to each disease. The key areas of her expertise include molecular biology, biophysics, and advanced structural determination methods such as cryo-electron microscopy and others to uncover early molecular mechanisms of disease. A goal of structural biology is to understand how form translates to function of a protein. In Carol’s research she studies what cellular dysfunction results in specific structural forms of protein aggregates unique to each neurodegenerative disease such as Alzheimer’s disease.